Health AlertsFDA Public Health Advisory Suspended Marketing of Tysabri (natalizumab)Thursday, July 14th, 2005FDA is issuing this public health advisory to inform patients and health care providers about the suspended marketing of Tysabri (natalizumab) due to two serious adverse events reported with its use. New Imaging Tests Shed Light on Brain Matter Changes in Relatives of Patients With MSMonday, July 15th, 2002According to a recently published study, relatives of patients with MS have a higher risk of developing MS than the general population. The study to evaluate risk involved 30 relatives of patients at the Department of Neurology, Medical Academy in Lodz, Poland, and the Department of Neuroscience, Scientific Institute and University Ospedale San Raffaele, in [...] Enzyme That May Contribute to MS Identified in the BrainMonday, July 15th, 2002A study at the Florida State University has discovered an unusual brain enzyme that may contribute to MS. Research focused on the enzyme known myelencephalon-specific pro enzyme. The enzyme, which relatively new discovery, is found in animals and humans. Results of the study indicate that the enzyme attacks proteins and myelin-sheathed nerve cells brain, which [...] Stem Cell Transplants May Be Effective for Patients With MSTuesday, July 9th, 2002News Flash From the American Academy of Neurology (AAN) Urinary Tract Infections (UTIs) and Multiple Sclerosis: Connection Between UTIs and Neurological Progression?Tuesday, July 9th, 2002Expert Consultant |
|